In Vitro Colorectal Cancer Testing Market by Test Types (Fecal Occult Blood Tests, Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test, Immuno-FOB ELISA Test, Stool Biomarkers Tests , Cologuard, M2-PK Stool Test, Blood Biomarker Tests, ColoSentry, ColoVantage, Epi proColon, mS9), and Product Pipeline (Cologic, Colox, MarCarePlex, MeScore CRC, miRSIGN, PanC – Dx) and Forecast 2017-2021

In Vitro Colorectal Cancer Testing Market by Test Types (Fecal Occult Blood Tests, Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test, Immuno-FOB ELISA Test, Stool Biomarkers Tests , Cologuard, M2-PK Stool Test, Blood Biomarker Tests, ColoSentry, ColoVantage, Epi proColon, mS9), and Product Pipeline (Cologic, Colox, MarCarePlex, MeScore CRC, miRSIGN, PanC – Dx) and Forecast 2017-2021

The majority of colorectal cancers begin as benign growths in the lining of the large bowel wall called adenomatous polyps. Over the years (at least ten years), these polyps grow in size and number, thereby increasing the risk that the cells in the polyps will become cancerous and invade the wall and move on to other organs. Approximately two thirds of these cancers are found in the large intestine and one third in the rectum. Early removal of these growths will prevent colorectal cancer from developing in the first place. Hence, identification and removal of polyps are key to preventing the development of colorectal cancer. Screening for colorectal cancer allows for the early detection of cancer when it is highly curable, as well as the detection of growths (polyps) that might eventually become cancer. Currently, two types of FOBT are approved by the Food and Drug Administration (FDA) to screen for colorectal cancer: guaiac FOBT (gFOBT) and the fecal immunochemical (or immunohistochemical) test (FIT, also known as iFOBT).

The global in vitro colorectal cancer testing market report provides market size (Revenue USD Million 2014 to 2021), market share and forecasts growth trends (CAGR%, 2017 to 2021).

The global in vitro colorectal cancer testing market segmentation is based on test types (Fecal Occult Blood Tests, Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test, Immuno-FOB ELISA Test, Stool Biomarkers Tests , Cologuard, M2-PK Stool Test, Blood Biomarker Tests, ColoSentry, ColoVantage, Epi proColon, mS9), and Product Pipeline (Cologic, Colox, MarCarePlex, MeScore CRC, miRSIGN, PanC – Dx).

The global in vitro colorectal cancer testing market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and also tracks the major competitors operating in the market and provides analysis of the company overview, financial snapshot, key products, technologies and services offered, market share analysis and recent trends in the global market. The global in vitro colorectal cancer testing market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

Major players operating in the global in vitro colorectal cancer testing market and included in this report are Abbott Molecular, Inc., Alere, Inc, Beckman Coulter, Inc., BioTime, Inc., Epigenomics AG, Quest Diagnostics, Exact Sciences Corporation, Novigenix SA, CML Healthcare, Inc., and Sysmex Corporation.

Category:
  1. Introduction
  2. Executive Summary
    • Market Size Estimation (Revenue USD Million, 2014-2021)
    • Forecast Estimation (Revenue USD Million and CAGR%, 2017-2021)
  3. Research Methodology
  4. Market Landscape
    • Market Dynamics
      • Drivers
      • Barriers
      • Opportunities
    • Market Share Analysis
      • Companies
      • Products
    • Market Trends Analysis
      • Key success factors
      • Market Growth Rate
    • Market Attractiveness Analysis
    • Market Profitability Analysis
      • Buyer power
      • Supplier power
      • Barriers to entry
      • Threat of substitute products
      • Rivalry among firms in the industry
    • Distribution Channels
  5. Market Segmentation [refer Market Segments and Companies Tab]
    • Product Type (cells, media, serum, vaccine, protein, instrument, etc.)
    • Source Type
    • Reagents and Consumables Type
    • Diagnostic Test
    • Indication Type
    • Technology
    • Diagnostics, Therapeutic or Surgical Application
    • End User Groups
  6. Geography (Region, Country)
    • North America (U.S., Canada)
    • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    • Latin America (Brazil, Mexico, Rest of LA)
    • Asia Pacific (Japan, China, India, Rest of APAC)
    • Rest of the World (Middle East & Africa)
  7. Company Profiles [refer Market Segments and Companies Tab]
    • Company Overview
    • Financial Snapshot (FY 2014-2016)
    • Product Portfolio
    • Business Strategies
    • Recent Developments
  8. Recommendations
  9. References

In vitro Colorectal Cancer Testing Market

1. Test Type
1.1. Fecal Occult Blood Tests
1.1.1. Guaiac FOB Stool Test
1.1.2. Immuno-FOB Agglutination Test
1.1.3. Lateral Flow Immuno-FOB Test
1.1.4. Immuno-FOB ELISA Test
1.2. Stool Biomarkers Tests
1.2.1. Cologuard
1.2.2. M2-PK Stool Test
1.2.3. Other Tests
1.3. Blood Biomarker Tests
1.3.1. ColoSentry
1.3.2. ColoVantage
1.3.3. Epi proColon
1.3.4. mS9
1.3.5. Other Tests

2. Product Pipeline
2.1. Cologic
2.2. Colox
2.3. MarCarePlex
2.4. MeScore CRC
2.5. miRSIGN
2.6. PanC – Dx

3. Geography (Region, Country)
3.1. North America (U.S., Canada)
3.2. Latin America (Brazil, Mexico, Rest of LA)
3.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
3.4. Asia Pacific (Japan, China, India, Rest of APAC)
3.5. Rest of the World

4. Company Profiles
4.1. Abbott Laboratories, Inc.
4.2. Alere, Inc.
4.3. Beckman Coulter, Inc.
4.4. Sysmex Corporation
4.5. Quest Diagnostics, Inc
4.6. Epigenomics AG
4.7. Exact Sciences Corporation
4.8. BioTime, Inc.
4.9. CML Healthcare, Inc.
4.10. Novigenix SA

Request market specific full ToC and sample pages for this report

Full Name*

Email*

Phone Number* [Please add country code]

Subject*

Message*